Inspire Medical Systems
INSP
103 hedge funds and large institutions have $628M invested in Inspire Medical Systems in 2018 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 45 increasing their positions, 15 reducing their positions, and 13 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
200% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 15
123% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 13
61% more capital invested
Capital invested by funds: $390M → $628M (+$239M)
21.62% more ownership
Funds ownership: 43.37% → 64.98% (+22%)
18% more funds holding
Funds holding: 87 → 103 (+16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.1M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$23M |
| 3 |
Morgan Stanley
New York
|
+$20M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.4M |
| 5 |
BlackRock
New York
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$26.1M |
| 2 |
HCM
Hodges Capital Management
Dallas,
Texas
|
-$3.21M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.11M |
| 4 |
Walleye Trading
New York
|
-$2.15M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
-$1.76M |
INSP Hedge Fund Activity: Q4 2018 in Review
103 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q4 2018, worth a combined $628M — up 61% from $390M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new INSP positions and 13 closed out — a net gain of 16 holders — while 45 added to existing stakes and 15 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $26.1M. The largest seller was OrbiMed, cutting an estimated $26.1M.
- 103 institutional investors held Inspire Medical Systems (INSP) as of Q4 2018, up from 87 in Q3 2018.
- Funds reported $628M of Inspire Medical Systems stock for Q4 2018, up 61% quarter-over-quarter.
- 29 funds opened new Inspire Medical Systems positions in Q4 2018 and 13 closed out, a net change of +16 holders.
- The largest Inspire Medical Systems buyer in Q4 2018 was T. Rowe Price Associates, an estimated $26.1M added.
- The largest Inspire Medical Systems seller in Q4 2018 was OrbiMed, an estimated $26.1M sold.
Based on aggregated 13F filings for Q4 2018.